Description

Trenaxa (Tranexamic Acid) Solution for Injections 100 mg/ml. 10 ml. Vials №5

Ingredients

Active ingredient: Tranexamic acid. Other ingredients may include water for injection.

Dosage

The usual dosage: The recommended dose of Trenaxa is 10 mg/kg body weight, administered intravenously. Dosage may vary based on the condition being treated.

Indications

Trenaxa is indicated for:

• Prevention and control of excessive bleeding during surgery.
• Treatment of heavy menstrual bleeding.
• Management of hemorrhagic complications in patients with hemophilia.

Contraindications

Do not use Trenaxa if:

• You are allergic to tranexamic acid.
• You have a history of blood clots.
• You have color vision changes.

Directions

Administer Trenaxa: Trenaxa is for intravenous use only. It should be administered by healthcare professionals following proper dilution and dosage guidelines.

Scientific Evidence

Tranexamic acid: Tranexamic acid, the active ingredient in Trenaxa, works by inhibiting the breakdown of blood clots, thereby reducing bleeding. Studies have shown its effectiveness in various clinical settings, including reducing blood loss during surgery and managing heavy menstrual bleeding.

Additional Information

Pharmacological Effects: Tranexamic acid exerts its effects by blocking the enzymatic breakdown of fibrin clots, promoting hemostasis. It is a valuable tool in preventing excessive bleeding in various medical conditions.

Clinical Trials: Clinical trials have demonstrated the efficacy of tranexamic acid in reducing blood loss and transfusion requirements in surgical patients. Research published in the Journal of Trauma and Acute Care Surgery showed a significant reduction in blood loss in patients receiving tranexamic acid compared to a control group.